Update in Thyroid Fine Needle Aspiration
|
|
- Gervais Gaines
- 6 years ago
- Views:
Transcription
1 Endocr Pathol (2011) 22: DOI /s Update in Thyroid Fine Needle Aspiration William C. Faquin & Massimo Bongiovanni & Peter M. Sadow Published online: 14 October 2011 # Springer Science+Business Media, LLC 2011 Abstract Thyroid fine needle aspiration (FNA) is a safe, cost effective, and relatively accurate method for guiding the initial management of a thyroid nodule. The popularity of thyroid FNA is reflected in the fact that over 350,000 thyroid FNAs are performed each year in the USA. As we move into the next decade, several issues pertaining to thyroid FNA are being addressed including: how to better apply thyroid FNA as a differential test for follicularpatterned thyroid tumors, how to manage the atypical thyroid FNA, and how to use thyroid FNA in the evaluation of poorly differentiated thyroid carcinomas. Keywords Thyroid. FNA. Cytology. Follicular-patterned lesions. Bethesda. Poorly differentiated carcinoma Introduction Over the past three decades, fine needle aspiration (FNA) has become the most accurate and cost-effective method for guiding the initial clinical management of patients with thyroid nodules [1 4]. Over 350,000 thyroid FNAs are performed W. C. Faquin (*) : P. M. Sadow Department of Pathology, WRN 219, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA WFaquin@Partners.org W. C. Faquin : P. M. Sadow Harvard Medical School, Boston, MA, USA M. Bongiovanni Institute of Pathology, Locarno, Switzerland each year in the USA, and approximately 60 70% of these are diagnosed as benign, avoiding the need for surgery in these patients [3]. In experienced hands, the mean reported accuracy of thyroid FNA is 76.8%, with a range from 53% to 95%; however, it is difficult to evaluate the accuracy for benign thyroid aspirates because these nodules are infrequently resected [3, 5 12]. Thyroid FNA specimens containing follicular cell-derived lesions are the most commonly encountered and include various forms of benign thyroid nodules (e.g., colloid nodules, adenomatous nodules, follicular adenomas), follicular carcinomas, papillary carcinomas and its many variants, poorly differentiated thyroid carcinomas, and undifferentiated carcinomas. Several challenges exist for thyroid cytology as we move through the next decade including (1) how to apply thyroid FNA more effectively as a differential test for follicular-patterned thyroid lesions, (2) how to diagnose and report the atypical thyroid FNA, and (3) how to recognize poorly differentiated carcinomas by thyroid FNA. FNA as a Screening Test for Follicular-Patterned Thyroid Lesions The large number of benign thyroid nodules relative to the small number of malignant ones creates a clinical dilemma how to manage patients with a detectable thyroid enlargement that statistically is more likely to be benign? Thyroid FNA is used as a screening test for follicular and Hurthle cell carcinomas while it is often a diagnostic test for other follicular cell-derived cancers such as papillary carcinoma. There are limitations of thyroid FNA as a screening test for follicular-patterned lesions. Once the decision to aspirate the thyroid nodule is made, there is a 20 40%
2 Endocr Pathol (2011) 22: Table 1 Six-tiered Bethesda System for Reporting of Thyroid Cytopathology* Diagnostic category Management Implied risk of malignancy (%) Non-diagnostic or unsatisfactory Repeat FNA 1 4 Benign Follow 0 3 Atypia of undetermined significance or follicular lesion of undetermined Repeat FNA 5 15 significance Suspicious for follicular neoplasm or follicular neoplasm (specify if oncocytic type) Lobectomy Suspicious for malignancy Lobectomy/total thyroid Malignant Total thyroidectomy *Modified from Cibas and Ali [18] chance that the patient will undergo a partial or total thyroidectomy and, in a majority of these cases, the resected thyroid nodule will be benign [1, 2, 4, 13]. Ancillary molecular markers are in the early stages of being applied to thyroid FNA samples, but with recent advances, there are good prospects that thyroid FNA in the near future might be used as a diagnostic test for follicular and Hurthle cell tumors. Future molecular markers may take the form of a panel of ATA recommended markers or an expression profile [14 17]. Another limitation of thyroid FNA is that its use has been plagued by inconsistencies in reporting terminology between laboratories both within the USA and throughout the world. Until very recently, there has been no uniform, standardized, and internationally recognized system for reporting the results of thyroid FNA. Several classification schemes had been suggested by various authors and adopted by different societies, including the Papanicolaou Society of Cytopathology in 1997, the American Thyroid Association in 2006, the American Association of Clinical Endocrinologists and the Associazione Medici Endocrinologi in 2006, the Royal College of Physician-British Thyroid Association, and the Italian Society of Anatomic Pathology and Cytopathology. The recently published, six-tiered Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) represents a major step towards standardization and reproducibility of thyroid FNA [18, 19]. The six diagnostic categories used in the Bethesda system are (Table 1): (1) non-diagnostic or unsatisfactory, (2) benign, (3) atypia of undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS), (4) suspicious for a follicular neoplasm (±oncocytic features) or follicular neoplasm, (5) suspicious for malignancy, and (6) malignant. An important aspect of this system is that each diagnostic category is associated with a relative risk of malignancy that ranges from 0 3% in the benign category to nearly 100% for the malignant category. In addition, each diagnostic category can be linked to a clinical management algorithm. In this way, a major role of thyroid FNA is to provide a relative risk of malignancy upon which clinicians, endocrinologists, and surgeons can base their management decisions. While the application of thyroid FNA as a screening test for follicular carcinoma is generally straightforward, one follicular-patterned thyroid lesion which can be particularly problematic is the follicular variant of papillary thyroid carcinoma (FVPTC). In FNA specimens, it can pose a diagnostic pitfall due to the abundance of microfollicles or monolayer tissue fragments mimicking a follicular neoplasm (Fig. 1a). In fact, among those FNAs diagnosed as suspicious for a follicular neoplasm that are malignant in histologic follow-up, over 30% are identified as the FVPTC [20 22]. In contrast to the hyperchromatic chromatin seen in follicular neoplasms, the classic FVPTC exhibits pale, powdery chromatin along with nuclear grooves and occasional intranuclear pseudoinclusions, but in a subset of cases, the nuclear findings will be subtle (Fig. 1b). The cells of the FVPTC tend to be round to oval and less pleomorphic than the conventional type of papillary carcinoma. Variable amounts of dense colloid are frequently seen in the FVPTC, and multinucleated giant cells may also be identified. The sometimes subtle nuclear features combined with the follicular cytomorphology results in the diagnosis of many of these tumors as suspicious for a follicular neoplasm or as AUS/FLUS. Molecular tests for RET/PTC rearrangements or point mutations of the BRAF gene in routine thyroid FNA samples can be used to detect classical PTC, but are often less useful for the FVPTC since the latter is often characterized by RAS mutations rather than BRAF mutations or RET PTC gene rearrangements [14 17]. In fact, a major obstacle to the application of molecular markers to thyroid FNA is the fact that currently available markers tend to work well with lesions that are readily diagnosed microscopically by thyroid FNA but are less useful for the difficult thyroid FNA lesions diagnosed as AUS/FLUS, suspicious for a follicular neoplasm, orsuspiciousforfvptc.
3 180 Endocr Pathol (2011) 22: Fig. 1 Follicular variant of papillary thyroid carcinoma. a A microfollicular architecture combined with oval pale, grooved nuclei can be seen in a majority of cases. b A subset of cases will have subtle nuclear features that can be difficult to recognize by thyroid FNA. (Smears, Papanicoloau stain) The Atypical Thyroid FNA The reporting of borderline atypia in thyroid aspirates has historically been problematic. Approximately 10% of thyroid FNAs exhibit some form of atypia of uncertain significance which is often related to a variety of benign cellular changes, but in some cases, it reflects an underlying malignancy. TBSRTC has addressed the issue of the atypical thyroid FNA by introducing the AUS/FLUS category [18]. The AUS/FLUS category is the most controversial of TBSRTC diagnostic categories, and as further studies are performed, the category will continue to be better defined. According to TBSRTC, the AUS/FLUS category is reserved for aspirates that contain follicular, lymphoid, or other cell types with architectural and/or nuclear atypia that is more pronounced than that observed in benign/reactive lesions yet not sufficient to be classified as suspicious for a follicular neoplasm, suspicious for malignancy, or malignant [18, 23] As such, the AUS/FLUS category is a heterogeneous one, and because of the general nature of the AUS/FLUS category, it has the potential to be overused. TBSRTC recommends that the AUS/FLUS category should not exceed 7% of FNA thyroid diagnoses; however, in recent studies, the rates of AUS/FLUS have varied from 3% to 20% signaling that adjustments in the recommended rates of AUS/FLUS may be needed [24 29]. QA metrics applied to the AUS/FLUS category within individual labs may be useful to keep its rate within a reasonable level. The risk of malignancy associated with the AUS/FLUS category is estimated at 5% to 15%, and the suggested management algorithm based upon this diagnosis is a repeat FNA [21, 23, 27]. Based upon recent evidence in the literature, surgery should be considered for those patients who have a repeat thyroid FNA that is also AUS/FLUS [21, 23, 27]. TBSRTC defines eight different scenarios for the use of the AUS/FLUS category including a sparsely cellular aspirate with a predominance of microfollicles (Fig. 2a), cytologic atypia in the setting of preparation artifact, Fig. 2 The AUS/FLUS category. a This hypocellular thyroid FNA lacked sufficient cells to meet adequacy criteria, but the few groups present were primarily microfollicles. b This thyroid FNA contained rare follicular cells with nuclear atypia in an otherwise benign-appearing aspirate. (Smears, Papanicoloau stain)
4 Endocr Pathol (2011) 22: oncocytic atypia, and focal atypia suggestive of papillary carcinoma in an otherwise predominantly benign-appearing sample (Fig. 2b). One of the most common scenarios is the presence of a compromised specimen due to scant cellularity, partial air-drying, or obscuring blood. Already, since the publication of TBSRTC, there have been many studies published pertaining to the AUS/FLUS category. Some studies have suggested that the AUS/FLUS category might be further subdivided [25, 30], particularly with regard to the presence of focal cytologic features of papillary carcinoma. Such nuclear atypia has been shown to confer a higher risk of malignancy than other AUS patterns [25, 30], while architectural atypia alone is half as likely to be malignant as other patterns. As experience is gained with TBSRTC in general and with AUS/FLUS in particular, it is expected that the criteria for AUS/FLUS will be further refined. Furthermore, it is likely that some form of molecular testing will one day play an important role in triaging patients with an AUS/FLUS diagnosis. FNA of Poorly Differentiated Thyroid Carcinoma Poorly differentiated thyroid carcinoma (PDTC) is a rare thyroid cancer of follicular cell origin that has distinct clinical, histological, and biological characteristics that were further defined in 2007 by the Turin Proposal [31]. PDTC has an aggressive clinical behavior intermediate between that of WDTCs and undifferentiated (anaplastic) thyroid carcinomas [32 36] While PDTC represents an extremely important clinical entity, few studies have examined its cytologic features, and aspirates of PDTC represent a diagnostic challenge for the cytopathologist. One of the first cytological descriptions of PDTCs was a report of 6 cases by Pietribiasi et al. in 1990, followed by 4 cases in 1992 by Sironi et al., 6 cases in 1999 by Guiter et al., 5 cases in 2001 by Nguyen et., and 40 cases by our group in 2009 [37 41]. In addition to these series, a limited number of published case reports are also available, but only a few FNAB cases have prospectively recognized the tumors as PDTC. Aspirates of PDTC are typically cellular with severely crowded clusters and scant colloid although some cases can show single cells [37]. The insular type will often display a recognizable insular cytoarchitectural pattern at low magnification (Fig. 3a). The malignant cells are small with scant delicate cytoplasm and a high nuclear/cytoplasmic ratio. Nuclei are generally round, mildly hyperchromatic, and cytologically uniform although some cases will exhibit nuclear grooves and prominent nucleoli, and occasionally cells are highly pleomorphic. Necrosis within the smear background and increased mitotic activity are cytologic features that help distinguish PDTC from the usual follicular neoplasm (Fig. 3b). While a cytologic diagnosis of malignancy can be made in a subset of cases, for many PDTC cases, the lesion will be diagnosed as suspicious for a follicular neoplasm. Using stepwise logistic regression analysis, a combination of insular, solid, or trabecular cytoarchitectural patterns, single cells, high N/C ratio, and severe crowding have been shown to be the most useful in combination for predicting PDTC in FNA samples [37]. Currently, no specific immunohistochemical or molecular markers exclusively expressed in PDTCs have been identified to aid the cytologic diagnosis. High molecular weight cytokeratins, thyroglobulin, TTF-1, HBME-1, galectin-3, CD44v6, p3, PAX8-PPARγ1, and Bcl-2 have been identified in PDTCs, but these markers do not distinguish between WDTC and PDTC [42, 43]. The molecular biology of PDTCs is not well understood. A high prevalence of Ras mutations ranging from 18% to 63% has been found in PDTCs, but this is not a specific molecular feature [44, 45]. As more advances are made on Fig. 3 Poorly differentiated thyroid carcinoma. a This aspirate is cellular and contains follicular cells with high N/C ratio in a crowded insular arrangement. b Background necrotic debris can be seen in a subset of PDTC cases. (Smears, Papanicoloau stain)
5 182 Endocr Pathol (2011) 22: the molecular front using cohorts defined by the Turin Proposal, it may be possible to provide more objective diagnostic markers for cytologic specimens. References 1. Werga P, Wallin G, Skoog L, Hamberger B. Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management. World J Surg 2000; 24: Lundgren CI, Zedenius J, Skoog L. Fine-needle aspiration biopsy of benign thyroid nodules: an evidence-based review. World J Surg 2008; 32: Bukhari MH, Niazi S, Hanif G, et al. An updated audit of fine needle aspiration cytology procedure of solitary thyroid nodule. Diagn Cytopathol 2008; 36: Deveci MS, Deveci G, LiVolsi VA, Baloch ZW. Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-up. Cytojournal 2006;3: Cramer H. Fine-needle aspiration cytology of the thyroid: an appraisal. Cancer 2000; 90: Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993; 118: Ravetto C, Colombo L, Dottorini ME. Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 2000; 90: Layfield LJ, Elsheikh TM, Fili A, Nayar R, Shidham V. Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting: the Papanicolaou Society of Cytopathology Practice Guidelines Task Force. Diagn Cytopathol 2004; 30: Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Diagn Cytopathol 1996; 15: Clark D, Faquin W. Thyroid Cytopathology. Essentials in Cytopathology Series. New York: Springer Oertel YC. Fine-needle aspiration of the thyroid: technique and terminology. Endocrinol Metab Clin North Am 2007; 36: , vi-vii. 12. Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner JR. Longterm follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery 1989; 106: 980 5; discussion Renshaw AA. An estimate of risk of malignancy for a benign diagnosis in thyroid fine-needle aspirates. Cancer Cytopathol 2010;118: Kato MA, Fahey TJ. Molecular markers in thyroid cancer diagnostics. Surg Clin N Am 2009;89: Nikiforov YE, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 2009;94: Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 2008;21:S37-S Ohori NP et al. Contribution of molecular testing to thyroid fineneedle aspiration cytology of follicular lesion of undetermined significance/atypia of undetermined significance. Cancer Cytopathol 2010;118: Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. New York, Springer, Baloch ZW, LiVolsi VA. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol 2008;36: Baloch ZW, Fleisher S, et al. Diagnosis of follicular neoplasm : a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26: Faquin WC, Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according tonational Cancer Institute Recommendations. Diagn Cytopathol 2010;10: Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer Cytopathol 2007;111: Krane JF, Nayar R, Renshaw AA. Atypical cells of undetermined significance. In: Ali SZ, Cibas ES, editors. The Bethesda system for reporting thyroid cytopathology. New York: Springer, 2010: Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol. 2009;117: Renshaw AA. Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: Distinct patterns and associated risk of malignancy. Cancer Cytopathol doi: /cncy Muddegowda PH, Lingegowda J, Natesan R, Kurpad R. Divide and rule: Cytodiagnosis of thyroid lesions using pattern analysis: A study of 233 cases. Diagn Cytopathol doi: /dc Shi Y, Ding X, Klein M, et al. Thyroid fine-needle aspiration with atypia of undetermined significance: a necessary or optional category? Cancer Cytopathol. 2009;117: Jing X, Roh MH, Knoepp SM, Zhao L, Michael CW. Minimizing the diagnosis of "follicular lesion of undetermined significance" and identifying predictive features for neoplasia. Diagn Cytopathol. 2011;39: MahajanA,KasperK,LinX,etal.ThyroidFNAatypiaof undetermined significance (AUS): variability in pathologist reporting and clinical follow-up. Mod Pathol. 2011;24 (1 s):98a. 30. Weber D, Brainard J, Chen L. Atypical epithelial cells, cannot exclude papillary carcinoma, in fine needle aspiration of the thyroid. Acta Cytol. 2008;52: Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31: Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer. 1983;52: Volante M, Landolfi S, Chiusa L, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer. 2004;100: Wreesmann VB, Ghossein RA, Patel SG, et al. Genome-wide appraisal of thyroid cancer progression. Am J Pathol 2002;161 (5): Luna-Ortiz K, Hurtado-Lopez LM, Dominguez-Malagon H, et al. Clinical course of insular thyroid carcinoma. Med Sci Monit. 2004;10:CR Pulcrano M, Boukheris H, Talbot M, et al. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification. Thyroid. 2007;17: Bongiovanni M, Bloom L, Krane JF, et al. Cytomorphologic features of poorly differentiated thyroid carcinoma: a multiinstitutional analysis of 40 cases. Cancer. Cytopathol Pietribiasi F, Sapino A, Papotti M, et al. Cytologic features of poorly differentiated 'insular' carcinoma of the thyroid, as revealed by fineneedle aspiration biopsy. Am J Clin Pathol. 1990;94:
6 Endocr Pathol (2011) 22: Sironi M, Collini P, Cantaboni A. Fine needle aspiration cytology of insular thyroid carcinoma. A report of four cases. Acta Cytol. 1992;36: Guiter GE, Auger M, Ali SZ, et al. Cytopathology of insular carcinoma of the thyroid. Cancer. 1999;87: Nguyen GK, Akin MR. Cytopathology of insular carcinoma of the thyroid. Diagn Cytopathol. 2001;25: Albores-Saavedra J, Carrick K. Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol 2004;15: Raphael SJ. The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia. Endocr Pathol. 2002;13: Basolo F, Pisaturo F, Pollina LE, et al. N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression. Thyroid. 2000;10: Garcia-Rostan G, Zhao H, Camp RL, et al. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol. 2003;21:
DIAGNOSIS AND REPORTING OF FOLLICULAR-PATTERNED THYROID LESIONS BY FINE NEEDLE ASPIRATION
Follicular-patterned thyroid lesions, WC Faquin 1 DIAGNOSIS AND REPORTING OF FOLLICULAR-PATTERNED THYROID LESIONS BY FINE NEEDLE ASPIRATION William C. Faquin, M.D., Ph.D Department of Pathology, Massachusetts
More informationBackground to the Thyroid Nodule
William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director of Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital THYROID FNA: PART I Background to the
More informationCase #1. Ed Stelow, MD University of Virginia
Case #1 Ed Stelow, MD University of Virginia Imagine, If You Will It s 4:30 on Friday Last cytology case A thyroid FNA from outside that did not have any onsite interpretation It is from a 45-year old
More informationUsefulness of Diagnostic Qualifiers for Thyroid Fine-Needle Aspirations With Atypia of Undetermined Significance
Anatomic Pathology / AUS Qualifiers in Thyroid FNAs Usefulness of Diagnostic Qualifiers for Thyroid Fine-Needle Aspirations With Atypia of Undetermined Significance Paul A. VanderLaan, MD, PhD, 1 Ellen
More informationThyroid Cytopathology: Weighing In The Bethesda System
Thyroid Cytopathology: Weighing In The Bethesda System V8 Conflicts No financial consideration Bias Work in the Canadian environment where litigation is less Thyroid cytology is often referred in by small
More informationFNA of Thyroid. Toward a Uniform Terminology With Management Guidelines. NCI NCI Thyroid FNA State of the Science Conference
FNA of Thyroid NCI NCI Thyroid FNA State of the Science Conference Toward a Uniform Terminology With Management Guidelines Thyroid Thyroid FNA Cytomorphology NCI Thyroid FNA State of the Science Conference
More informationPotential Pitfalls for False Suspicion of Papillary Thyroid Carcinoma:
SUPPLEMENT 1 SPECIAL ISSUE: CYTOPATHOLOGY OF THE THYROID GLAND Guest Editor: Zubair Baloch Potential Pitfalls for False Suspicion of Papillary Thyroid Carcinoma: A Cytohistologic Review of 22 Cases Xin
More informationThyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS
Thyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS Attending Pathologist Rhode Island Hospital, Providence, RI DISCLOSURE:
More informationClinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations Should Repeated FNA Be the Preferred Initial Approach?
Anatomic Pathology / Clinical Outcome for AUS Thyroid FNA Clinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations Should Repeated FNA Be the Preferred Initial Approach?
More informationThyroid follicular neoplasms in cytology. Ulrika Klopčič Institute of Oncology, Department of Cytopathology, Ljubljana, Slovenia
Thyroid follicular neoplasms in cytology Ulrika Klopčič Institute of Oncology, Department of Cytopathology, Ljubljana, Slovenia Lecture overview importance of FNAB in assessing thyroid lesions follicular
More information"Atypical": Criteria and
"Atypical": Criteria and Controversies Esther Rossi MD PhD MIAC Division of Anatomic Pathology and Cytology Catholic University of Sacred Heart Rome, Italy CASE HISTORY In 2015, 45 y/o woman underwent
More informationTHYROID CYTOLOGY THYROID CYTOLOGY FINE-NEEDLE-ASPIRATION ANCILLARY TESTS IN THYROID FNA
ANCILLARY TESTS IN THYROID FNA Prof. Fernando Schmitt Department of Pathology and Oncology, Medical Faculty of Porto University Head of Molecular Pathology Unit, IPATIMUP General-Secretary of the International
More informationPredictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases
Predictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases Can Potential Clues of Malignancy Be Identified? Mohammad Jaragh, MD 1 ; V. Bessie Carydis, MMedSci (Cytol) 1 ; Christina
More informationThe Atypical Thyroid Fine-Needle Aspiration: Past, Present, and Future
The Atypical Thyroid Fine-Needle Aspiration: Past, Present, and Future Massimo Bongiovanni, MD 1 ; Jeffrey F. Krane, MD, PhD 2 ; Edmund S. Cibas, MD 2 ; and William C. Faquin, MD, PhD 3 Thyroid fine-needle
More information3/22/2017. Disclosure of Relevant Financial Relationships. Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC
Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC Tarik M. Elsheikh, MD Professor and Medical Director Anatomic Pathology Cleveland Clinic Laboratories Disclosure
More informationLet s Make Sense of Present & Predict Future. In Light of Past 1/12/2016
The New Diagnostic Paradigms in Thyroid Surgical Pathology and Affects on Reporting of Thyroid Fine Needle Aspiration Specimens Deliberations, Criticisms & Discussions Zubair W. Baloch, MD, PhD. Professor
More informationCN 925/15 History. Microscopic Findings
CN 925/15 History 78 year old female. FNA indeterminate lesion right thyroid lobe. Previous THY1C (UK) Bethesda category 1 cyst fluid. Ultrasound showed part solid/cystic changes, indeterminate in nature
More informationNIFTP Cytologic Aspects
NIFTP Cytologic Aspects William C. Faquin, MD PhD Director, Head and Neck Pathology Massachusetts General Hospital & Massachusetts Eye and Ear Infirmary Boston, MA USA So, what is the story about FVPTC
More informationsystem and the Bethesda system applied for reporting thyroid cytopathology
Original Research Article A comparative study between conventional system and the Bethesda system applied for reporting thyroid cytopathology M. Mamatha 1*, S. Chandra Sekhar 2, H. Sandhya Rani 3, S. Sandhya
More informationTBSRTC 1- Probabilistic approach and Relationship to Clinical Algorithms
The Benefits of a Uniform Reporting System for Thyroid Cytopathology BETHESDA REPORTING SYSTEM Prof. Fernando Schmitt Department of Pathology and Oncology, Medical Faculty of Porto University Head of Molecular
More informationACCME/Disclosures. Questions to Myself? 4/11/2016
The New Diagnostic Paradigms in Thyroid Surgical Pathology and Affects on Reporting of Thyroid Fine-Needle Aspiration Specimens Deliberations, Criticisms & Discussions Zubair W. Baloch, MD, PhD. Professor
More informationIntroduction 10/27/2011. Follicular Lesion/Atypia of Undetermined Significance
Follicular Lesion/Atypia of Undetermined Significance Tarik M. Elsheikh, MD Cleveland Clinic Cleveland, Ohio Diagnostic Categories Proposed by Bethesda System/NCI Thyroid Conference 1. Benign 2. Follicular
More informationCytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC
Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC Tarik M. Elsheikh, MD Professor and Medical Director Anatomic Pathology Cleveland Clinic Laboratories Case Study
More informationFollicular Derived Thyroid Tumors
Follicular Derived Thyroid Tumors Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for Medical Sciences
More informationThe Indeterminate Thyroid Fine-Needle Aspiration
The Indeterminate Thyroid Fine-Needle Aspiration Experience From an Academic Center Using Terminology Similar to That Proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State
More informationThyroid master class. Thyroid Fine needle aspiration cytology and liquid-based techniques: Hologic and Becton Dickinson
Thyroid master class Thyroid Fine needle aspiration cytology and liquid-based techniques: Hologic and Becton Dickinson Principle of LBC Collection of cells in liquid medium Immediate fixation Processor-prepared
More informationBuilding On The Best A Review and Update on Bethesda Thyroid 2017
Building On The Best A Review and Update on Bethesda Thyroid 2017 Syed Z. Ali, MD, FRCPath, FIAC Professor of Pathology and Radiology The Johns Hopkins Hospital, Baltimore, Maryland USA TBSRTC Diagnostic
More informationUltrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events
Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events Sandrine Rorive, M.D., PhD. Erasme Hospital - Université Libre de Bruxelles (ULB) INTRODUCTION The assessment of thyroid nodules
More informationNCI Thyroid FNA State of the Science Conference. The Bethesda System For Reporting Thyroid Cytopathology
The Bethesda System For Reporting Thyroid Cytopathology Towards a Uniform Terminology With Management Guidelines NCI Thyroid FNA State of the Science Conference Bethesda, MD October 22-23, 2007 154 registrants
More informationKyle C. Strickland, MD, PhD; Brooke E. Howitt, MD; Justine A. Barletta, MD; Edmund S. Cibas, MD Jeffrey F. Krane, MD, PhD
Suggesting the Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP): A Retrospective Analysis of Atypical and Suspicious Nodules Kyle C. Strickland,
More informationXIII CONGRESSO NAZIONALE Roma, 7-9 novembre NODULO TIROIDEO: Agoaspirato o Core Needle Biopsy?
XIII CONGRESSO NAZIONALE NODULO TIROIDEO: Agoaspirato o Core Needle Biopsy? Anna Crescenzi Policlinico Universitario Campus Bio-Medico Roma Indeterminate lesions are heterogeneous The gray zone CONSERVATIVE
More informationCytopathological evaluation of various thyroid lesions based on Bethesda system for reporting thyroid lesions
International Journal of Research in Medical Sciences Khadatkar AS et al. Int J Res Med Sci. 2017 Apr;5(4):1339-1343 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20170901
More informationThe Frozen Section: Diagnostic Challenges and Pitfalls
The Frozen Section: Diagnostic Challenges and Pitfalls William C. Faquin, M.D., Ph.D. Director, Head and Neck Pathology Massachusetts General Hospital & Massachusetts Eye and Ear Infirmary Harvard Medical
More informationCase year old female presented with asymmetric enlargement of the left lobe of the thyroid
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationCase 4 Diagnosis 2/21/2011 TGB
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationUpdate on Thyroid FNA The Bethesda System. Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center
Update on Thyroid FNA The Bethesda System Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center Thyroid Nodules Frequent occurrence Palpable: 4-7% of adults Ultrasound: 10-31% Majority benign
More informationThyroid FNA: Diagnosis, Challenges and Solutions. Disclosures
Thyroid FNA: Diagnosis, Challenges and Solutions Zubair W. Baloch, MD, PhD None Disclosures 1 Questions to Myself? Where We are Now? The Present 2 Reality Check There is More to How Thyroid Nodules are
More informationJournal of Diagnostic Pathology 2011 (6); 1: Leading Article
Leading Article Beyond the horizon of current thyroid cytology reporting in Sri Lanka... Lokuhetty MDS Thyroid enlargement is a commonly encountered clinical problem among Sri Lankan patients, be it diffuse
More informationCase #1 FNA of nodule in left lobe of thyroid in 67 y.o. woman
Challenging Cases Manon Auger M.D., F.R.C.P. (C) Professor, Department of Pathology McGill University Director, Cytopathology Laboratory McGill University it Health Center Case #1 FNA of nodule in left
More informationHow to Interpret Thyroid Fine-Needle Aspiration Biopsy Reports: A Guide for the Busy Radiologist in the Era of the Bethesda Classification System
Neuroradiology/Head and Neck Imaging Review Dhyani et al. How to Interpret FNAB Results of Thyroid Nodules Neuroradiology/Head and Neck Imaging Review Manish Dhyani 1 William Faquin 2 Carrie C. Lubitz
More informationThe Korean Journal of Cytopathology 15(1) : 60-64, 2004
15 1 The Korean Journal of Cytopathology 15(1) : 60-64, 2004 : INTRODUCTION Papillary carcinoma of the thyroid gland has for long been traditionally diagnosed on the basis of the characteristic papillary
More informationThe Bethesda Indeterminate Categories: An Update to Diagnosis and Molecular Testing
William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director, Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital The Bethesda Indeterminate Categories:
More informationASC Companion Meeting at the 2017 USCAP: Ancillary Molecular Testing in "Indeterminate. Thyroid Nodules: How Far Have We Come?
ASC Companion Meeting at the 2017 USCAP: Ancillary Molecular Testing in "Indeterminate Thyroid Nodules: How Far Have We Come? William C. Faquin, MD, PhD, Massachusetts General Hospital, Boston, MA The
More informationFine Needle Aspiration Cytology of Thyroid Follicular Neoplasm: Cytohistologic Correlation and Accuracy
The Korean Journal of Pathology 2013; 47: 61-66 ORIGINAL ARTICLE Fine Needle Aspiration Cytology of Thyroid Follicular Neoplasm: Cytohistologic Correlation and Accuracy Changyoung Yoo Hyun Joo Choi Soyoung
More information3/27/2017. Disclosure of Relevant Financial Relationships. Each year over 550,000 thyroid FNAs are performed in the U.S.!!! THYROID FNA: THE GOOD NEWS
Disclosure of Relevant Financial Relationships William C. Faquin, MD, PhD Director, Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital Professor of Pathology Harvard Medical
More informationCytology for the Endocrinologist. Nicole Massoll M.D
Cytology for the Endocrinologist Nicole Massoll M.D Objectives Discuss slide preperation Definitions of adequacy ROSE (Rapid On-Site Evaluation) Thyroid Cytology Adequacy Nicole Massoll M.D. University
More informationINTRODUCTION. Original Article. Jiyeon Hyeon, MD 1 ; Soomin Ahn, MD 1 ; Jung Hee Shin, MD, PhD 2 ; and Young Lyun Oh, MD, PhD 1
The Prediction of Malignant Risk in the Category Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance of the Bethesda System for Reporting Thyroid Cytopathology Using Subcategorization
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Validity Assessment of The Bethesda System for Reporting Thyroid Cytopathology Ranjana Solanki
More informationSalivary Gland Cytology: A Clinical Approach to Diagnosis and Management of Atypical and Suspicious Lesions
Salivary Gland Cytology: A Clinical Approach to Diagnosis and Management of Atypical and Suspicious Lesions W.C. Faquin, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School, USA Marc Pusztaszeri,
More informationThe Bethesda System for Reporting Thyroid Cytopathology, Laila Khazai 11/4/17
The Bethesda System for Reporting Thyroid Cytopathology, 2017 Laila Khazai 11/4/17 In Summary No major changes for cytologists. The clinical team is faced with different risk of malignancies (ROM) associated
More informationTHE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A TWO YEAR INSTITUTIONAL AUDIT
IJCRR Section: Healthcare Sci. Journal Impact Factor 4.016 Research Article THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY: A TWO YEAR INSTITUTIONAL AUDIT Salma Bhat 1, Nazia Bhat 1, Humaira Bashir
More informationComparison of Thyroid Fine-Needle Aspiration and Core Needle Biopsy
Anatomic Pathology / THYROID FNA AND CORE NEEDLE BIOPSY Comparison of Thyroid Fine-Needle Aspiration and Core Needle Biopsy Andrew A. Renshaw, MD, 1 and Nat Pinnar, MD 2 Key Words: Thyroid; Neoplasia;
More informationCLINICAL MEDICAL POLICY
Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Molecular Markers for Fine Needle Aspirates of Thyroid Nodules MP-065-MD-DE Medical Management Provider Notice Date: 10/15/2018;
More information04/09/2018. Follicular Thyroid Tumors Updates in Classification & Practical Tips. Dissecting Indeterminants. In pursuit of the low grade malignancy
Follicular Thyroid Tumors Updates in Classification & Practical Tips Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University
More informationNew entities in thyroid pathology: update according to the WHO classification
New entities in thyroid pathology: update according to the WHO classification R.R. de Krijger, Dept. of Pathology, University Medical Center and Princess Maxima Center, Utrecht, The Netherlands New issues
More informationAn Alphabet Soup of Thyroid Neoplasms
Overall Objectives An Alphabet Soup of Thyroid Neoplasms Lester D. R. Thompson www.lester-thompson.com What is the current management of papillary carcinoma? What are the trends and what can we do differently?
More informationCytological Evaluation of Thyroid Lesions Based on the Bethesda System.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-086.Volume 5, Issue 2 Ver. VII (December. 206), PP 2-7 www.iosrjournals.org Cytological Evaluation of Thyroid Lesions
More informationOverview of Indeterminate Cytology
83 rd Annual Meeting American Thyroid Association Overview of Indeterminate Cytology Scott Boerner MD FRCPC Head Cytopathology, University Health Network University of Toronto DISCLOSURE Nothing to disclose
More informationRole of fine needle aspiration cytology and cytohistopathological co-relation in thyroid lesions: experience at a tertiary care centre of North India
International Journal of Research in Medical Sciences Chandra S et al. Int J Res Med Sci. 2016 Oct;4(10):4552-4556 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20163328
More informationVolume 2 Issue ISSN
Volume 2 Issue 3 2012 ISSN 2250-0359 Correlation of fine needle aspiration and final histopathology in thyroid disease: a series of 702 patients managed in an endocrine surgical unit *Chandrasekaran Maharajan
More informationCYTOPATHOLOGY OF FOLLICULAR CELL NODULES
104 th Annual USCAP Meeting Boston, March 21-27, 2015 Endocrine Pathology Society. March 21, 2015 Follicular cell-derived tumors of the thyroid gland, a practical update CYTOPATHOLOGY OF FOLLICULAR CELL
More informationA Cytohistological Correlation in Thyroid Swelling with Special Reference to The Bethesda System: A Study of 192 Cases.
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 10 Ver. XI (Oct. 2017), PP 55-59 www.iosrjournals.org A Cytohistological Correlation in Thyroid
More informationNoninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan
2017, 64 (12), 1149-1155 Original Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan Mitsuyoshi Hirokawa 1), Miyoko Higuchi 2), Ayana
More informationThe Bethesda system for reporting thyroid cytopathology: Should Sri Lanka adopt it?
The Bethesda system for reporting thyroid cytopathology: Should Sri Lanka adopt it? Professor. Chandu de Silva Chair and Senior Professor of Pathology Department of Pathology, Faculty of Medicine, University
More informationMolecular Testing for Indeterminate Thyroid Nodules. October 20, 2018
Molecular Testing for Indeterminate Thyroid Nodules October 20, 2018 Patient 1: Left 1.0 cm AP x 1.6 cm transverse x 2.1 cm in length Well defined Isoechoic heterogeneous No calcification Grade 3 Vascularity
More informationAtypia of undetermined significance on thyroid fine needle aspiration: surgical outcome and risk factors for malignancy
ORIGINAL ARTICLE pissn 2288-6575 eissn 2288-6796 http://dx.doi.org/10.4174/astr.2014.86.3.109 Annals of Surgical Treatment and Research Atypia of undetermined significance on thyroid fine needle aspiration:
More informationThe Bethesda System for Reporting Thyroid Cytopathology
AJCP / Special Article The Bethesda System for Reporting Thyroid Cytopathology Edmund S. Cibas, MD, 1 and Syed Z. Ali, MD 2 Key Words: Thyroid; Cytology; Fine-needle aspiration; Terminology Abstract To
More informationRepeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results
Anatomic Pathology / REPEAT THYROID FINE-NEEDLE ASPIRATION Repeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results Melina B. Flanagan, MD, MSPH, 1 N. Paul Ohori,
More informationThyroid Cytopathology: What s New and What s Old That We Don t All Agree on?
Thyroid Cytopathology: What s New and What s Old That We Don t All Agree on? RITU NAYAR, MD PROFESSOR & VICE CHAIR OF PATHOLOGY NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE DIRECTOR OF CYTOPATHOLOGY,
More informationDownloaded from by John Hanna on 11/09/15 from IP address Copyright ARRS. For personal use only; all rights reserved
Neuroradiology/Head and Neck Imaging Original Research Zhu et al. Ultrasound Versus Afirma Testing of FNA-Indeterminate Thyroid Nodules Neuroradiology/Head and Neck Imaging Original Research Qing-Li Zhu
More informationClinical Significance of Distinguishing Between Follicular Lesion and Follicular Neoplasm in Thyroid Fine-Needle Aspiration Biopsy
Ann Surg Oncol (2009) 16:3146 3153 DOI 10.1245/s10434-009-0666-3 ORIGINAL ARTICLE ENDOCRINE TUMORS Clinical Significance of Distinguishing Between Follicular Lesion and Follicular Neoplasm in Thyroid Fine-Needle
More informationCytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP
Endocrine Journal 2012, 59 (6), 483-487 Or i g i n a l Cytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP Keiko Nishigami 1), Zhiyan
More informationASCP Competency Assessment
ASCP Competency Assessment Thyroid Cytopathology Ricardo R. Lastra, MD Michelle R. Pramick, MD Zubair W. Baloch, MD, PhD Department of Pathology & Laboratory Medicine University of Pennsylvania, Perelman
More informationPOORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT?
POORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT? AGGRESSIVE THYROID CANCERS PAPILLARY CARCINOMA CERTAIN SUBTYPES POORLY DIFFERENTIATED CARCINOMA HIGH GRADE DIFFERENTIATED
More informationMolecular Markers in Fine Needle Aspirates of the Thyroid
Molecular Markers in Fine Needle Aspirates of the Thyroid Policy Number: 2.04.78 Last Review: 3/2014 Origination: 3/2013 Next Review: 3/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will
More information5/3/2017. Ahn et al N Engl J Med 2014; 371
Alan Failor, M.D. Clinical Professor of Medicine Division of Metabolism, Endocrinology and Nutrition University of Washington April 20, 2017 No disclosures to report 1. Appropriately evaluate s in adult
More informationBarriers to the Recognition of Medullary Thyroid Carcinoma on FNA: Implications Relevant to the New American Thyroid Association Guidelines
Barriers to the Recognition of Medullary Thyroid Carcinoma on FNA: Implications Relevant to the New American Thyroid Association Guidelines Kathryn S. Dyhdalo, MD and Deborah J. Chute, MD BACKGROUND: The
More informationTHE CONTRIBUTION OF CLINICAL AND RADIOLOGICAL FEATURES TO THE DIAGNOSIS IN AUS/FLUS AND FN/SFN THYROID NODULES
Acta Medica Mediterranea, 2016, 32: 151 THE CONTRIBUTION OF CLINICAL AND RADIOLOGICAL FEATURES TO THE DIAGNOSIS IN AUS/FLUS AND FN/SFN THYROID NODULES LUTFI DOGAN*, MEHMET ALI GULCELIK*, NIYAZI KARAMAN*,
More informationInter-observer reproducibility using The Besthesda System for Reporting Thyroid Cytopathology (TBSRTC)
SHORT COMMUNICATION Inter-observer reproducibility in thyroid cytology reporting Inter-observer reproducibility using The Besthesda System for Reporting Thyroid Cytopathology (TBSRTC) Doshi Neena 1*, Jhabuawala
More informationMedical Policy Manual. Topic: Molecular Markers in Fine Needle Aspirates of the Thyroid. Date of Origin: April 2013
Medical Policy Manual Topic: Molecular Markers in Fine Needle Aspirates of the Thyroid Date of Origin: April 2013 Section: Genetic Testing Last Reviewed Date: April 2014 Policy No: 49 Effective Date: July
More informationRates of thyroid malignancy by FNA diagnostic category
Williams et al. Journal of Otolaryngology - Head and Neck Surgery 2013, 42:61 ORIGINAL RESEARCH ARTICLE Open Access Rates of thyroid malignancy by diagnostic category Blair A Williams 1*, Martin J Bullock
More informationFINE NEEDLE ASPIRATION OF THE THYROID
FNA of the Thyroid 2011, WC Faquin 1 FINE NEEDLE ASPIRATION OF THE THYROID William C. Faquin, M.D., Ph.D. Director, Head and Neck Pathology Massachusetts General Hospital Massachusetts Eye and Ear Infirmary,
More informationAGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS
AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS PAPILLARY THYROID CARCINOMA Clinical Any age Microscopic to large Female: Male= 2-4:1 Radiation history Lymph nodes Prognosis
More informationEnterprise Interest None
Enterprise Interest None Risk stratification of salivary gland lesions on cytology based on the proposed Milan System for reporting salivary gland cytopathology: A pilot study Kartik Viswanathan, M.D.,
More informationSalivary gland tumor cytologic and histologic correlation: Algorithmic and risk stratification based approaches
Salivary gland tumor cytologic and histologic correlation: Algorithmic and risk stratification based approaches Christopher C. Griffith, MD, PhD Raja R. Seethala, MD 1. Salivary gland tumor cytology: A
More informationCase # year old man with a 2 cm right kidney mass
Case # 4. 52 year old man with a 2 cm right kidney mass Figure 1 Figure 2 Figure 3 Figure 4 Diagnosis: Negative/Non-diagnostic Normal kidney tissue Fine needle aspiration (FNA) of the kidney is performed
More informationIntroduction: Ultrasound guided Fine Needle Aspiration: When and how
International Course of Thyroid Ultrasonography and minimally invasive procedure 7-8 October 2016 University of Pisa, Italy Introduction: Ultrasound guided Fine Needle Aspiration: When and how Teresa Rago
More informationDOWNLOAD ENTIRE DOCUMENT FROM
PREVIEW ONLY 1 Atlas on Bethesda system for reporting Thyroid Cytology PREVIEW ONLY 2 OVERVIEW 1. Indications and goal of thyroid FNA 2. Contraindications 3. Procurement of cell sample 4. Staining methods
More informationThe diagnostic value of fine-needle aspiration cytology in the assessment of thyroid nodules: a retrospective 5-year analysis
The diagnostic value of fine-needle aspiration cytology in the assessment of thyroid nodules: a retrospective 5-year analysis GPS Yeoh, KW Chan Objective. To audit the diagnostic accuracy and value of
More informationDilemmas in Cytopathology and Histopathology
Dilemmas in Cytopathology and Histopathology Yuri E. Nikiforov, MD, PhD Division of Molecular & Genomic Pathology University of Pittsburgh Medical Center, USA Objectives Discuss new WHO classification
More informationClinical Study Diagnosis of Follicular Lesions of Undetermined Significance in Fine-Needle Aspirations of Thyroid Nodules
Thyroid Research Volume 2013, Article ID 250347, 6 pages http://dx.doi.org/10.1155/2013/250347 Clinical Study Diagnosis of Follicular Lesions of Undetermined Significance in Fine-Needle Aspirations of
More informationPathology Reporting of Thyroid Core Needle Biopsy: A Proposal of the Korean. Endocrine Pathology Thyroid Core Needle Biopsy Study Group
Pathology Reporting of Thyroid Core Needle Biopsy: A Proposal of the Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group Chan Kwon Jung 1 Hye Sook Min 2,3 Hyo Jin Park 2 Dong Eun Song 4 Jang
More informationSection 2 Original Policy Date 2013 Last Review Status/Date September 1, 2014
Policy Number 2.04.82 Molecular Markers in Fine Needle Aspirates of the Thyroid Medical Policy Section 2 Original Policy Date 2013 Last Review Status/Date September 1, 2014 Disclaimer Our medical policies
More information40 TH EUROPEAN CONGRESS 0F CYTOLOGY LIVERPOOL, UK October 2-5, 2016
Outcomes from the diagnostic approach of thyroid lesions using US-FNA and LBC in clinical practice Emmanouel Mastorakis MD PhD Cytopathologist Director in Cytopathology Laboratory Regional General Hospital
More informationThyroid nodules are a common clinical presentation, with
Original Research Endocrine Surgery Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade Otolaryngology Head and Neck Surgery
More informationMarkers in Thyroid Nodule Evaluation. Yuri E. Nikiforov, MD, PhD Division of Molecular & Genomic Pathology University of Pittsburgh Medical Center
Markers in Thyroid Nodule Evaluation Yuri E. Nikiforov, MD, PhD Division of Molecular & Genomic Pathology University of Pittsburgh Medical Center Disclosures Quest Diagnostics (consultant) UPMC/CBLPath
More informationScholars Academic Journal of Biosciences (SAJB)
Scholars Academic Journal of Biosciences (SAJB) Abbreviated Key Title: Sch. Acad. J. Biosci. Scholars Academic and Scientific Publisher A Unit of Scholars Academic and Scientific Society, India www.saspublisher.com
More informationDifferences between Follicular Variant and Conventional Papillary Thyroid Carcinoma According to Fine-needle Aspiration Cytology
Journal of Basic & Clinical Medicine http://www.sspublications.org/index.php/jbcm/index Differences between Follicular Variant and Conventional Papillary Thyroid Carcinoma According to Fine-needle Aspiration
More informationClinical and Molecular Approach to Using Thyroid Needle Biopsy for Nodular Disease
Clinical and Molecular Approach to Using Thyroid Needle Biopsy for Nodular Disease Robert L. Ferris, MD, PhD Department of Otolaryngology/Head and Neck Surgery and Yuri E. Nikiforov, MD, PhD Division of
More informationCytodiagnosis of thyroid lesions with histopathological correlation and evaluation of discrepant cases
Research Article Cytodiagnosis of thyroid lesions with histopathological correlation and evaluation of discrepant cases Shaista Mushtaq Hamdani, Ruby Reshi Department of Pathology, Government Medical College,
More information